News Opinion Editor's Corner AHA 2021 AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More Shelley Wood November 08, 2021
News Daily News Predictors of AF May Help Guide Care After Stroke of Unknown Cause Caitlin E. Cox October 26, 2021
News Daily News Rivaroxaban Again Linked to More Bleeding vs Other DOACs Caitlin E. Cox October 11, 2021
News Daily News AHA: More Screening Needed to Catch Myocardial Injury After Noncardiac Surgery Yael L. Maxwell October 04, 2021
News Daily News Dual Bests Triple Therapy in Nonvalvular AF Patients in RE-DUAL PCI Yael L. Maxwell April 09, 2021
News Daily News Observational Study Supports Continuing Oral Anticoagulation During PCI Michael O'Riordan April 06, 2021
News Daily News Antithrombotics for Elderly CAD Patients: One Size Doesn’t Fit All L.A. McKeown April 05, 2021
News Daily News ABC-Bleeding Score Stratifies Risk in A-fib Patients on OAC and Aspirin Todd Neale September 21, 2020
News Daily News More Evidence of Lower Fracture Risk With DOACs Versus Warfarin Todd Neale May 19, 2020
News Daily News How COVID-19 Promotes Thrombosis, Posing Problems for Drug-Drug Interactions Michael O'Riordan April 22, 2020
News Daily News Choosing a DOAC? Apixaban May Have an Edge Over Rivaroxaban Todd Neale March 09, 2020
News Daily News New Meta-analysis Supports NOAC Plus P2Y12 Inhibitor for PCI in A-fib Shelley Wood February 28, 2020
News Daily News No Stroke Reduction but Increased Bleeding With OAC in Dialysis Patients Todd Neale January 21, 2020
News Daily News Switch Anticoagulants for A-fib Patients Needing a Stent? RE-DUAL PCI Insights Shelley Wood December 02, 2019
News Daily News Dabigatran Discontinuation Rate Highest Early After Treatment Begins Todd Neale November 12, 2019
News Conference News TCT 2019 AUGUSTUS: Apixaban-Based Dual Therapy Best Across Major Subgroups Todd Neale September 26, 2019